| Metric | Value (₹ Cr) | Q1 FY27 | Q2 FY26 |
|---|---|---|---|
| Revenue | 1.0K | 14.0% | 0.1% |
| Total Income | 1.1K | 13.8% | 1.1% |
| Expenditure | 733.14 | 4.7% | 4.8% |
| PBT | 323.01 | 29.1% | 6.2% |
| Net Profit | 227.66 | 38.2% | 13.1% |
| OPM | 56.17% | 2.14pp | 2.48pp |
| NPM | 21.56% | 8.54pp | 3.52pp |
| EPS | 2.50 | 18.0% | 11.3% |
Flat growth masks strong underlying momentum, cost inflation clouds near-term outlook
The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.
Hold
confidence 6/10
Grade B
Affordable Housing met guidance (30% AUM YoY vs 25%+ target). Private markets on track. But overall revenue +0.1% vs implied 15-20% guidance expectation—significant miss.
Cautiously Optimistic
next 1–2 quarters
Optimistic
multi-year
JM Financial is executing well on long-term initiatives (20% revenue growth target, AUM expansion) and hit Affordable Housing guidance (+30% AUM YoY), but Q2 growth of +0.1% reveals execution gaps: deal compression ₹40-50 Cr, regulatory broking headwinds, and recruitment-driven cost inflation. Near-term revenue stagnation conflicts with confident guidance, making the risk/reward neutral at current valuation.
₹1032.2 Cr
Revenue · +0.1% YoY₹227.7 Cr
Reported PAT · −13.1% YoYCompressing
Margins · vs guidance: MixedDid the claims hold up?
Q2 results supported by strong capital markets performance
OVERSTATEDCapital markets revenue ₹286 Cr, up 2.5x QoQ but deal sizes compressed ₹40-50 Cr YoY. Overall revenue +0.1% YoY.
Private markets business seeing 20% YoY growth
METStandard loan book grew 22% YoY to ₹4,748 Cr, AUM ₹4,000 Cr up 30%. Claims aligned with actuals.
Affordable housing targeting 25%+ AUM growth
METAchieved 30% YoY AUM growth and 48% disbursement growth. Exceeded prior Q1 target of 28%.
Wealth AUM & loans showing very good traction
METWealth loan book ₹2,600 Cr (30% YoY), recurring AUM ₹37,000 Cr (16% YoY). Growth solid but revenue impact diluted by broking headwinds.
Earnings quality
What changed since the last call
Deal velocity improving post-June slump
UpgradeJune-July weak; Sept strong. Management now says momentum 'decent' in October. But September was cherry-picked; overall Q2 revenue still +0.1% YoY.
Revenue guidance reiterated at 20% blended, not raised
NeutralManagement confirmed 15-20% growth for capital markets, 20% loan book growth for private markets, 20-25% AUM for wealth. No upward revision despite earlier Q1 optimism.
ARC business now 'lumpy' per management framing
DowngradeExpected ₹250-300 Cr recovery by March, vs prior guidance of steady earnings lift. Timing uncertainty introduced.
Wealth productivity efforts yield near-term cost, not margin gain
DowngradeTeam rationalization underway; profitability recovery delayed to FY28. Near-term NPM pressure continues.
The Q&A
Analysts pressed hard on the revenue growth paradox—strong AUM/loan book growth across segments but flat consolidated revenue. Management deflected with FVD swings, ARC lumpiness, and deal compression. Dodged on buyback specifics; acknowledged capital constraints. Held firm on 20% long-term guidance despite near-term weakness.
Capital markets deal pipeline — Digant Haria, GreenEdge Wealth
PartialPipeline ₹130K Cr filed with regulator. June was weak, Sept strong. Primary market interest and FPI participation returned. October 'decent', November expected 'pretty decent'. But deal sizes compressed ₹40-50 Cr this quarter.
Private credit loan book trajectory — Pavan Kumar, Edelweiss Public Alternatives
AnsweredCash is healthy buffer at ₹1K Cr minimum. We will resume borrowing next quarter as yield improves. Management disciplined on risk-adjusted returns, will not chase growth if returns deteriorate.
Wealth AUM growth slowdown — Anubhav Goel, Cosma Ventures
PartialMarket-to-market effect. On steady-state growth basis, will add at 20%+ rates. Recruitment investment will drive growth in double digits over time, not immediately.
Capital deployment and buyback — Sanjay Pandit, 1729 Capital
AnsweredNBFC capital stuck; cannot easily exit. NSE stock just listed, locked up for six months. Will revisit buyback after March 2027 when NSE lockup expires. One year creep in capital plans.
Revenue growth reconciliation — Akshay Jawahar, Banyan Tree Associates
PartialNet gain on fair value changes (ARC side), broking revenue lower due to regulatory changes, write-backs ₹231 Cr last year vs ₹15 Cr this year. Half-on-half net revenue is actually ₹357 Cr (FY26) vs ₹582 Cr (FY27)—63% growth. Ignore quarterly volatility.
Wealth management new hire productivity — Kanishk Gupta, SS Family Office
AnsweredNew cohort: ₹75 Cr per RM. Existing cohort: ₹75-100 Cr per RM (mature). New cohort will be half that initially, but will double on ramp-up. Profitability recovery delayed to FY28.
Recurring vs transactional revenue split — Nilesh Doshi, Prospero Tree AMC
AnsweredYes. 50% from broking (12-15% of total recurring), institutional AUM growth, wealth recurring, and lending recurring. Rest 50% is transactional (M&A, deals, ARC recovery). Both businesses will grow, but transactional will remain volatile.
Guidance
Capital markets 15-20% growth over next 3-5 years
MediumIPO pipeline ₹183K Cr in Q2 suggests sustained momentum. But deal values compressed ₹40-50 Cr YoY; FY27 implies 12-15% growth, not 20%.
Private markets loan book 20% YoY growth
HighStandard loans grew 22% YoY to ₹4,748 Cr in Q2. Guidance reaffirmed; management disciplined on risk-adjusted returns.
Wealth management 20-25% AUM growth subject to market conditions
MediumRecurring AUM ₹37K Cr up 16% YoY; recruitment-driven productivity gains expected FY28. Current market volatility may cap near-term growth.
Overall revenue growth weighted ~20% YoY, 3-5 year horizon
MediumBlended across segments: capital markets (15-20%), private markets (20% loan book), wealth (20-25% AUM), affordable housing (25%+ AUM). FY27 actual +0.1% suggests guidance is 3-5Y forward-looking, not current FY.
Profitability to improve as recruitment phase matures
MediumWealth team expansion driving cost inflation; expected to normalize FY28. Operating leverage to drive margin expansion once recruitment cycle completes.
Risks the call surfaced
Capital markets cyclicality
High50% of revenue transactional (deals, M&A, capital markets). Q2 saw April-May weakness, Sept strength. Future quarters depend on market sentiment and IPO calendar.
Wealth management execution risk
MediumAggressive hiring (18 months of recruitment underway) is depressing near-term margins. Risk that new RMs do not reach mature RM productivity levels (₹75-100 Cr per RM target) in expected timeframe.
ARC and distressed credit volatility
MediumARC business subject to FVD changes and recovery timing lumpy. Q1 had ₹50+ Cr ARC recovery; Q2 quieter. Expected ₹250-300 Cr recovery by March uncertain.
Regulatory and broking headwinds
MediumWealth management includes broking revenue (12-15% of total recurring). Industry broking commissions lower in H1 vs H2 prior year. Regulatory environment may further compress margins.
Capital constraints and share liquidity
HighLarge capital deployed in NBFCs (illiquid); NSE stock just listed and locked up until March 2027. Limits capital deployment flexibility and shareholder returns. Stock trading below NAV but management cannot easily execute buyback.
Management
Score 7/10. Clear on segment metrics and strategy, transparent on headwinds (broking compression, deal size, recruitment costs). But deflected on buyback specifics and sometimes used 'market volatility' as catch-all excuse. Executing well on long-term initiatives (AUM growth, loan book expansion, Pre-IPO fund close) but missing near-term revenue targets (+0.1% YoY). Guidance of 15-20% growth not yet evidenced in quarterly delivery.
1 · Q3 FY27
Capital markets deal pipeline execution (₹130K Cr in filed transactions)
2 · March 2027
ARC ₹250-300 Cr recovery expected; NPA resolution ongoing
3 · Early FY28
Second performing credit fund first close; SIF platform launch
Near-term revenue stagnation conflicts with confident guidance, making the risk/reward neutral at current valuation.
Operational Momentum Masks the Revenue Problem
Loan books and AUM surged 20–30% across segments, yet consolidated revenue barely grew. Management blames deal compression and market volatility, but the real gap suggests structural headwinds in capital markets and a slow recovery in wealth profitability.
₹1032 Cr
+0.1% YoY (flat)
₹712 Cr
+12% YoY (strong)
₹228 Cr
-13.1% YoY (down)
₹10.3K Cr
+23% YoY
The quarter sits at a crossroads. On one lens, JM Financial's operational machine accelerated sharply—affordable housing AUM jumped 30% YoY, private credit loan book 22%, wealth AUM 16%. On the other, headline revenue inched forward just 0.1% YoY and profit fell 13%. The gap is not ambiguity; it is the story. Management's 15–20% three-year guidance now sits in stark tension with a quarter that delivered +0.1% organic growth, and the capital markets deal compression of ₹40–50 Cr YoY combined with regulatory broking headwinds explain only part of the miss.
Where the gap between AUM and revenue growth came from
Net revenue was ₹712 Cr, up 12% YoY—a healthy clip. But reported revenue of ₹1,032 Cr grew just 0.1%. The difference is not accounting fiction: capital advisory ₹286 Cr (down 2% YoY despite 2.5x QoQ pop), weak broking from regulatory headwinds, and fair-value volatility swings in ARC (₹120 Cr this quarter vs. ₹250+ Cr expected by March). The underlying business momentum is real—loan disbursements doubled YoY to ₹977 Cr, wealth loan book hit ₹2,600 Cr up 30% YoY—but has not yet translated into revenue per unit. Deal size compression (₹40–50 Cr YoY) is the concrete culprit in capital markets. Regulatory changes to broking commissions are the culprit in wealth. The profitability overhang is wealth management's 18-month recruitment cycle, which will normalize only in FY28.
Capital markets supported by strong capital advisory recovery
₹286 Cr capital advisory revenue, up 2.5x QoQ but down 2% YoY; deal size compressed ₹40–50 Cr. ₹183K Cr IPO volume ranked #1.
Supported (but upside overstated near-term)
Private markets seeing 20%+ growth, AUM scaling well
Standard loan book ₹4,748 Cr (+22% YoY); affordable housing AUM ₹4,000 Cr (+30% YoY); disbursements doubled to ₹977 Cr YoY.
Supported
Affordable housing hitting 25%+ AUM growth guidance
Achieved 30% YoY AUM growth; exceeded prior Q1 28% target.
Supported
Wealth AUM growth strong; profitability recovery on track
Wealth recurring AUM ₹37K Cr (+16% YoY); loan book ₹2.6K Cr (+30% YoY). But profitability recovery now FY28 vs. earlier implied FY27-end. New RM productivity ₹75 Cr vs mature ₹75–100 Cr.
Supported (but timeline slipped; margin drag persists)
What changed on this call
How the street is positioned
The stock sits at ₹112.66, down 43.61% from its all-time high of ₹199.8. It trades below its 20-day (₹113.16), 50-day (₹120.77), and 200-day (₹126.38) moving averages—a bearish technical setup. RSI of 45.9 signals no capitulation; the chart is orderly downtrend, not panic flush. FII ownership has declined from 18.38% to 16.95% over the past 18 months—a 143-basis-point reduction that signals foreign capital is rotating away despite balance-sheet quality. DII participation is steady at 5.5%. Volume is increasing on the decline, which often indicates conviction rather than forced liquidation.
This repricing is not a day-1 shock from the quarterly print; it is a multi-quarter rotational story. The market is questioning whether management can deliver the implied 15–20% revenue growth when Q2 delivered 0.1% YoY. The stock's 43% drawdown and position below all key moving averages suggests the market has begun to price either (a) a multi-year delay to margin recovery, or (b) a structural constraint in capital markets revenue that makes the 20% thesis unachievable near-term.
Private credit loan book +22% YoY; diversifying away from capital markets cyclicality
Affordable housing guidance beat (+30% AUM vs 25% target); improving margin economics
Pre-IPO Fund first close ₹700 Cr; alternative assets platforms scaling
Consolidated revenue +0.1% YoY despite strong AUM/loan growth signals structural margin pressure
Deal size compression ₹40–50 Cr; regulatory broking headwinds; both set to persist into H2
Wealth profitability inflection now FY28, not FY27-end; recruitment cost drag continues Q3–Q4
Capital constraints limit buyback and shareholder returns until post-March 2027
Stock down 43% from ATH; FII cut 140bps ownership; technicals below all moving averages
Capital markets deal size structural compression—may not normalize; fee pool shrinking per deal
HighIf deal sizes don't bounce back to prior ₹50+ Cr average, the headwind persists indefinitely. Management assumes normalization; if wrong, the 15–20% growth guidance is unachievable.
Wealth management profitability timeline creep—recruitment drag extends into FY28 and beyond
HighMargin expansion is the primary lever for EPS growth. If new RM ramp-up is slower than guided or market volatility dampens client AUM, margin recovery delays into FY29+, extending earnings headwind.
ARC recovery lumpiness—₹250–300 Cr expected by March, but timing and amount uncertain
MediumIf recovery lags into FY28 or realizes lower, Q3–Q4 earnings soften. If it accelerates, it masks continued operational weakness and risks disappointing Q3 FY28 by comparison.
Capital trapped—NBFC illiquidity and NSE lockup until March 2027 prevent strategic deployment
MediumStock at 0.4x NAV and 43% below ATH suggests capital returns would rerate equity; inability to execute on that caps upside. M&A optionality also constrained.
Foreign investor rotation—FII down 140bps; macroeconomic/geopolitical headwinds could extend the drawdown
MediumCapital advisory revenue (27% of total) is FPI-dependent. If India's growth outlook weakens or tariffs/geopolitics scare FPI away, deal flow and IPO activity contract directly.
1 · H2 capital markets deal pipeline execution
₹130K Cr filed with regulator for the second half. If deal velocity accelerates and deal sizes stabilise above ₹50 Cr average, it validates management's recovery narrative. If deal sizes remain compressed and volumes are lumpy, the market reprices capital advisory segment downward.
2 · ARC recovery realisation by March 2027
Management guides ₹250–300 Cr recovery by March FY28. If realised in Q3–Q4 FY27, it flattens YoY earnings comparison and should lift sentiment. If delayed into FY28 or materially lower, Q3–Q4 earnings remain soft.
3 · Wealth management productivity inflection—when do margins start to expand?
New RM cohort is at ₹75 Cr per RM; mature cohort ₹75–100 Cr. If new hires ramp to ₹85+ Cr per RM in H2 FY27, it validates the FY28 profitability inflection and could trigger re-rating. If productivity stalls and broking headwinds persist, margin pressure extends.
JM Financial is not a broken business. The operational engines—private credit, wealth, affordable housing, capital advisory—are all running. But they are running into headwinds (deal compression, regulatory margin pressure, recruitment drag) that management has identified but not yet overcome. The 15–20% multi-year growth thesis is plausible, but the execution gap is real. Revenue +0.1% YoY is not acceptable noise; it is a signal that near-term growth is stalled.
The stock's 43% drawdown from ATH and position below all moving averages reflects this recalibration. For holders, the question is not whether JM Financial executes over 3–5 years—the assets are strong and diversifying—but whether you can tolerate 2–3 more quarters of margin compression and near-flat revenue growth before inflection. For buyers, the valuation offers a margin of safety, but timing remains uncertain.
The single number to track: Consolidated net revenue growth (or segment-by-segment revenue per rupee of AUM/loan book). If that inflection begins to appear in Q3, it validates the thesis. If it remains near-flat, it signals a structural headwind rather than a temporary cyclical one.